Cargando…
Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
Tissue factor (TF) pathway inhibitor (TFPI) is a Kunitz-type anticoagulation protein that inhibits activated factor VII (FVIIa)/TF complex. Incidentally, many different F7 gene variants, including TFPI-binding exosite mutations, have been reported in patients with congenital FVII deficiency and clin...
Autores principales: | Seanoon, Karnsasin, Payongsri, Panwajee, Vivithanaporn, Pornpun, Sirachainan, Nongnuch, Chuansumrit, Ampaiwan, Hongeng, Suradej, Tanratana, Pansakorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661381/ https://www.ncbi.nlm.nih.gov/pubmed/35973191 http://dx.doi.org/10.1182/bloodadvances.2022007560 |
Ejemplares similares
-
Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line
por: Pongjantarasatian, Sarai, et al.
Publicado: (2019) -
Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
por: Chuansumrit, Ampaiwan, et al.
Publicado: (2010) -
Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?
por: Sasanakul, Werasak, et al.
Publicado: (2022) -
No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease
por: Lertthammakiat, Surapong, et al.
Publicado: (2020) -
Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)